Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Correction for Rossetto et al., Regulation of Viral and Cellular Gene Expression by Kaposi's Sarcoma-Associated Herpesvirus Polyadenylated Nuclear RNA.

Rossetto CC, Tarrant-Elorza M, Verma S, Purushothaman P, Pari GS.

J Virol. 2016 Mar 28;90(8):4255. doi: 10.1128/JVI.00171-16. Print 2016 Apr. No abstract available.

2.
3.

Maintenance and replication of the human cytomegalovirus genome during latency.

Tarrant-Elorza M, Rossetto CC, Pari GS.

Cell Host Microbe. 2014 Jul 9;16(1):43-54. doi: 10.1016/j.chom.2014.06.006.

4.

Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells.

Rossetto CC, Tarrant-Elorza M, Pari GS.

PLoS Pathog. 2013;9(5):e1003366. doi: 10.1371/journal.ppat.1003366. Epub 2013 May 23.

5.

Phosphorylation of Kaposi's sarcoma-associated herpesvirus processivity factor ORF59 by a viral kinase modulates its ability to associate with RTA and oriLyt.

McDowell ME, Purushothaman P, Rossetto CC, Pari GS, Verma SC.

J Virol. 2013 Jul;87(14):8038-52. doi: 10.1128/JVI.03460-12. Epub 2013 May 15.

6.

Regulation of viral and cellular gene expression by Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA.

Rossetto CC, Tarrant-Elorza M, Verma S, Purushothaman P, Pari GS.

J Virol. 2013 May;87(10):5540-53. doi: 10.1128/JVI.03111-12. Epub 2013 Mar 6. Erratum in: J Virol. 2016 Apr 15;90(8):4255.

7.

Analysis of the interactions of viral and cellular factors with human cytomegalovirus lytic origin of replication, oriLyt.

Kagele D, Rossetto CC, Tarrant MT, Pari GS.

Virology. 2012 Mar 15;424(2):106-14. doi: 10.1016/j.virol.2011.12.010. Epub 2012 Jan 10.

9.

DNA synthesis and late viral gene expression.

Anders DG, Kerry JA, Pari GS.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 19.

10.

Interaction of Kaposi's sarcoma-associated herpesvirus ORF59 with oriLyt is dependent on binding with K-Rta.

Rossetto CC, Susilarini NK, Pari GS.

J Virol. 2011 Apr;85(8):3833-41. doi: 10.1128/JVI.02361-10. Epub 2011 Feb 2.

11.

The carboxy-terminal segment of the human cytomegalovirus DNA polymerase accessory subunit UL44 is crucial for viral replication.

Silva LA, Loregian A, Pari GS, Strang BL, Coen DM.

J Virol. 2010 Nov;84(21):11563-8. doi: 10.1128/JVI.01033-10. Epub 2010 Aug 25.

12.

Nucleocytoplasmic shuttling of human cytomegalovirus UL84 is essential for virus growth.

Gao Y, Kagele D, Smallenberg K, Pari GS.

J Virol. 2010 Sep;84(17):8484-94. doi: 10.1128/JVI.00738-10. Epub 2010 Jun 23.

13.

Interaction of HCMV UL84 with C/EBPalpha transcription factor binding sites within oriLyt is essential for lytic DNA replication.

Kagele D, Gao Y, Smallenburg K, Pari GS.

Virology. 2009 Sep 15;392(1):16-23. doi: 10.1016/j.virol.2009.06.035. Epub 2009 Jul 23.

14.

The flexible loop of the human cytomegalovirus DNA polymerase processivity factor ppUL44 is required for efficient DNA binding and replication in cells.

Alvisi G, Roth DM, Camozzi D, Pari GS, Loregian A, Ripalti A, Jans DA.

J Virol. 2009 Sep;83(18):9567-76. doi: 10.1128/JVI.00669-09. Epub 2009 Jul 1.

15.
16.

Interaction of human cytomegalovirus pUL84 with casein kinase 2 is required for oriLyt-dependent DNA replication.

Gao Y, Pari GS.

J Virol. 2009 Mar;83(5):2393-6. doi: 10.1128/JVI.02339-08. Epub 2008 Dec 17.

17.

Role of homodimerization of human cytomegalovirus DNA polymerase accessory protein UL44 in origin-dependent DNA replication in cells.

Sinigalia E, Alvisi G, Mercorelli B, Coen DM, Pari GS, Jans DA, Ripalti A, Palù G, Loregian A.

J Virol. 2008 Dec;82(24):12574-9. doi: 10.1128/JVI.01193-08. Epub 2008 Oct 8.

18.

Nuts and bolts of human cytomegalovirus lytic DNA replication.

Pari GS.

Curr Top Microbiol Immunol. 2008;325:153-66. Review.

PMID:
18637505
19.
20.

Overexpression of the kaposi's sarcoma-associated herpesvirus transactivator K-Rta can complement a K-bZIP deletion BACmid and yields an enhanced growth phenotype.

Kato-Noah T, Xu Y, Rossetto CC, Colletti K, Papousková I, Pari GS.

J Virol. 2007 Dec;81(24):13519-32. Epub 2007 Oct 3.

21.

Human cytomegalovirus UL84 interacts with an RNA stem-loop sequence found within the RNA/DNA hybrid region of oriLyt.

Colletti KS, Smallenburg KE, Xu Y, Pari GS.

J Virol. 2007 Jul;81(13):7077-85. Epub 2007 Apr 25.

23.

Antisense approach for the treatment of cytomegalovirus infection.

Temsamani J, Pari GS, Guinot P.

Expert Opin Investig Drugs. 1997 Sep;6(9):1157-67.

PMID:
15991890
24.

Human cytomegalovirus UL84 is a phosphoprotein that exhibits UTPase activity and is a putative member of the DExD/H box family of proteins.

Colletti KS, Xu Y, Yamboliev I, Pari GS.

J Biol Chem. 2005 Mar 25;280(12):11955-60. Epub 2005 Feb 1.

25.
26.
27.

Human cytomegalovirus UL84 insertion mutant defective for viral DNA synthesis and growth.

Xu Y, Cei SA, Huete AR, Pari GS.

J Virol. 2004 Oct;78(19):10360-9.

29.

Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form.

Khaiboullina SF, Maciejewski JP, Crapnell K, Spallone PA, Dean Stock A, Pari GS, Zanjani ED, Jeor SS.

Br J Haematol. 2004 Aug;126(3):410-7.

PMID:
15257715
31.

Gene transfer into mammalian cells using calcium phosphate and DEAE-dextran.

Pari GS, Xu Y.

Methods Mol Biol. 2004;245:25-32. No abstract available.

PMID:
14707367
32.

Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein.

Rizvanov AA, van Geelen AG, Morzunov S, Otteson EW, Bohlman C, Pari GS, St Jeor SC.

J Virol. 2003 Nov;77(22):12203-10.

34.
35.

Replication of rhesus cytomegalovirus in life-expanded rhesus fibroblasts expressing human telomerase.

Chang WL, Kirchoff V, Pari GS, Barry PA.

J Virol Methods. 2002 Jul;104(2):135-46.

PMID:
12088823
36.
37.
38.

Identification of the rhesus macaque rhadinovirus lytic origin of DNA replication.

Pari GS, AuCoin D, Colletti K, Cei SA, Kirchoff V, Wong SW.

J Virol. 2001 Dec;75(23):11401-7.

39.

A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency.

Prichard MN, Gao N, Jairath S, Mulamba G, Krosky P, Coen DM, Parker BO, Pari GS.

J Virol. 1999 Jul;73(7):5663-70.

40.

Identification of persistent RNA-DNA hybrid structures within the origin of replication of human cytomegalovirus.

Prichard MN, Jairath S, Penfold ME, St Jeor S, Bohlman MC, Pari GS.

J Virol. 1998 Sep;72(9):6997-7004.

41.

Generation of a nude mouse tumor model for in vivo replication of human cytomegalovirus.

Pari GS, Netski D, St Jeor S, McCarthy D, Smith J, Georgio D, von Hofe E.

J Infect Dis. 1998 Mar;177(3):523-8.

PMID:
9498427
42.

Experimental strategies in efficient transfection of mammalian cells. Calcium phosphate and DEAE-dextran.

Pari GS, Keown WA.

Methods Mol Biol. 1997;62:301-6. No abstract available.

PMID:
9108529
43.
45.
46.

Human cytomegalovirus UL102 gene.

Smith JA, Pari GS.

J Virol. 1995 Mar;69(3):1734-40.

49.
50.

Supplemental Content

Support Center